| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANXA2
|
annexin A2
|
|
APOE
|
apolipoprotein E
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
CPB1
|
carboxypeptidase B1 (tissue)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTSV
|
cathepsin V
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DNASE1
|
deoxyribonuclease I
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
ENO1
|
enolase 1, (alpha)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGG
|
fibrinogen gamma chain
|
|
FN1
|
fibronectin 1
|
|
GSN
|
gelsolin
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H2BB
|
histone cluster 3, H2bb
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
IFNA1
|
interferon, alpha 1
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB6
|
integrin, beta 6
|
|
JAG1
|
jagged 1
|
|
KDR
|
kinase insert domain receptor
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KNG1
|
kininogen 1
|
|
KRT8
|
keratin 8, type II
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
MAG
|
myelin associated glycoprotein
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR193A
|
microRNA 193a
|
|
MIR193B
|
microRNA 193b
|
|
MIR21
|
microRNA 21
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP19
|
matrix metallopeptidase 19
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRC2
|
mannose receptor, C type 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
OSM
|
oncostatin M
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFD
|
platelet derived growth factor D
|
|
PGF
|
placental growth factor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLG
|
plasminogen
|
|
PON2
|
paraoxonase 2
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RELN
|
reelin
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SAA@
|
serum amyloid A1 cluster
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SERBP1
|
SERPINE1 mRNA binding protein 1
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SFTPB
|
surfactant protein B
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIGLEC14
|
sialic acid binding Ig-like lectin 14
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SP1
|
Sp1 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
SYK
|
spleen tyrosine kinase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBD
|
thrombomodulin
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TMPRSS11E
|
transmembrane protease, serine 11E
|
|
TP53
|
tumor protein p53
|
|
TRIM33
|
tripartite motif containing 33
|
|
USF1
|
upstream transcription factor 1
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VNN2
|
vanin 2
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
